• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

芬兰多发性硬化症的流行病学:地区差异和高发率。

Multiple sclerosis epidemiology in Finland: Regional differences and high incidence.

机构信息

Division of Clinical Neurosciences, Turku University Hospital, Turku, Finland.

Department of Neurology, University of Turku, Turku, Finland.

出版信息

Acta Neurol Scand. 2019 Apr;139(4):353-359. doi: 10.1111/ane.13057. Epub 2019 Jan 3.

DOI:10.1111/ane.13057
PMID:30480315
Abstract

OBJECTIVES

Studies on the east-west gradient of multiple sclerosis (MS) are scarce. In Finland, epidemiological differences have been only partially elucidated, but the MS risk is high, and it has been claimed that the occurrence follows a longitudinal gradient. In this register-based study, we updated the MS epidemiology in southwest Finland (SwF) and compared it to the easternmost hospital district, North Karelia (NK), for which no previous data exist.

MATERIALS AND METHODS

Patients with ICD-10 code G35 were identified from hospital district administrative data. Patient records were reviewed to include only cases with a definitive diagnosis. Incidence period covered 5 years (2012-2016), and the prevalence date was December 31, 2016. Results were standardized using the direct method.

RESULTS

A total of 1184 persons had MS in SwF and 253 persons in NK at the end of 2016. The prevalence was 280/100 000 (95% CI 264-296) in SwF and 168/100 000 (95% CI 148-190) in NK (age-standardized for the European standard population 2013). During the incidence period, 211 new MS diagnoses were made in SwF and 49 in NK. The annual age-standardized (ESP 2013) incidence was 12.1/100 000 person-years (95% CI 10.5-13.8) in SwF and 8.6/100 000 person-years (95% CI 6.4-11.2) in NK in the age-group 10-69 years.

CONCLUSIONS

There are regional differences in MS epidemiology in Finland, possibly related to demographic, social, and genetic circumstances, but the retrospective nature and limited sample size of this study might introduce some uncertainty to the calculations. SwF is a region with a globally very high risk for MS.

摘要

目的

多发性硬化症(MS)的东西梯度研究较少。在芬兰,流行病学差异仅部分阐明,但 MS 风险很高,有人声称其发生遵循纵向梯度。在这项基于登记的研究中,我们更新了芬兰西南部(SwF)的 MS 流行病学,并将其与以前没有数据的最东端医院区北卡累利阿(NK)进行了比较。

材料和方法

从医院区行政数据中确定 ICD-10 代码 G35 的患者。对患者记录进行审查,仅包括具有明确诊断的病例。发病期为 5 年(2012-2016 年),患病率日期为 2016 年 12 月 31 日。结果采用直接法标准化。

结果

到 2016 年底,SwF 共有 1184 人患有 MS,NK 有 253 人患有 MS。SwF 的患病率为 280/100 000(95%CI 264-296),NK 的患病率为 168/100 000(95%CI 148-190)(年龄标准化为 2013 年欧洲标准人口)。发病期间,SwF 确诊 211 例新 MS 病例,NK 确诊 49 例。10-69 岁年龄组中,SwF 的年标准化(ESP 2013)发病率为 12.1/100 000 人年(95%CI 10.5-13.8),NK 为 8.6/100 000 人年(95%CI 6.4-11.2)。

结论

芬兰的 MS 流行病学存在地域差异,可能与人口统计学、社会和遗传环境有关,但本研究的回顾性和有限的样本量可能会给计算带来一些不确定性。SwF 是全球 MS 风险非常高的地区。

相似文献

1
Multiple sclerosis epidemiology in Finland: Regional differences and high incidence.芬兰多发性硬化症的流行病学:地区差异和高发率。
Acta Neurol Scand. 2019 Apr;139(4):353-359. doi: 10.1111/ane.13057. Epub 2019 Jan 3.
2
Occurrence of multiple sclerosis in central Finland: a regional and temporal comparison during 30 years.芬兰中部多发性硬化症的发病情况:30年间的区域和时间比较
Acta Neurol Scand. 2004 Nov;110(5):331-6. doi: 10.1111/j.1600-0404.2004.00326.x.
3
Changes in multiple sclerosis epidemiology in Finland over five decades.多发性硬化症在芬兰五十年间的流行病学变化。
Acta Neurol Scand. 2020 Sep;142(3):200-209. doi: 10.1111/ane.13295. Epub 2020 Jun 24.
4
Risk of osteoporotic fractures in multiple sclerosis patients in southwest Finland.芬兰西南部多发性硬化症患者骨质疏松性骨折的风险。
Acta Neurol Scand. 2017 May;135(5):516-521. doi: 10.1111/ane.12623. Epub 2016 Jun 22.
5
Incidence of multiple sclerosis in the Republic of Ireland: A prospective population-based study.爱尔兰共和国多发性硬化症的发病率:一项前瞻性基于人群的研究。
Mult Scler Relat Disord. 2017 Apr;13:75-80. doi: 10.1016/j.msard.2017.02.010. Epub 2017 Feb 14.
6
Multiple sclerosis in Finland 2018-Data from the national register.2018 年芬兰多发性硬化症报告——国家注册中心数据
Acta Neurol Scand. 2019 Nov;140(5):303-311. doi: 10.1111/ane.13145. Epub 2019 Jul 29.
7
Increasing prevalence of multiple sclerosis in Finland.芬兰多发性硬化症患病率不断上升。
Acta Neurol Scand. 2001 Mar;103(3):153-8. doi: 10.1034/j.1600-0404.2001.103003153.x.
8
Prevalence and mortality of patients with multiple sclerosis in France in 2012: a study based on French health insurance data.2012年法国多发性硬化症患者的患病率和死亡率:一项基于法国医疗保险数据的研究。
J Neurol. 2017 Jun;264(6):1185-1192. doi: 10.1007/s00415-017-8513-0. Epub 2017 May 17.
9
Trigeminal neuralgia in multiple sclerosis: Prevalence and association with demyelination.多发性硬化症中的三叉神经痛:患病率及与脱髓鞘的关系。
Acta Neurol Scand. 2020 Aug;142(2):139-144. doi: 10.1111/ane.13243. Epub 2020 Apr 3.
10
Regional and temporal variation in the incidence of multiple sclerosis in Finland 1979-1993.1979 - 1993年芬兰多发性硬化症发病率的地区和时间差异。
Neuroepidemiology. 2000 Mar-Apr;19(2):67-75. doi: 10.1159/000026241.

引用本文的文献

1
Delays in treatment initiation for patients with relapsing-remitting multiple sclerosis-A nationwide population-based study.复发缓解型多发性硬化症患者治疗起始延迟——一项基于全国人口的研究。
Mult Scler J Exp Transl Clin. 2025 Aug 4;11(3):20552173251360358. doi: 10.1177/20552173251360358. eCollection 2025 Jul-Sep.
2
Methods of estimating prevalence of multiple sclerosis in six European healthcare data sources: a contribution from the ConcePTION project.六种欧洲医疗保健数据源中多发性硬化症患病率的估计方法:ConcePTION项目的一项贡献
Eur J Epidemiol. 2025 Jul 31. doi: 10.1007/s10654-025-01243-8.
3
Incidence and prevalence of multiple sclerosis during eras of evolving diagnostic criteria-a nationwide population-based registry study over five decades.
不断演变的诊断标准时代多发性硬化症的发病率和患病率——一项基于全国人群登记的五十年研究
Mult Scler J Exp Transl Clin. 2025 Mar 16;11(1):20552173251326173. doi: 10.1177/20552173251326173. eCollection 2025 Jan-Mar.
4
Multiple sclerosis: emerging epidemiological trends and redefining the clinical course.多发性硬化症:新出现的流行病学趋势及对临床病程的重新定义
Lancet Reg Health Eur. 2024 Aug 22;44:100977. doi: 10.1016/j.lanepe.2024.100977. eCollection 2024 Sep.
5
Multiple sclerosis in Denmark (1950-2023): mean age, sex distribution, incidence and prevalence.丹麦的多发性硬化症(1950 - 2023年):平均年龄、性别分布、发病率和患病率
Brain. 2025 Feb 3;148(2):626-634. doi: 10.1093/brain/awae245.
6
Pediatric traumatic brain injury and early age multiple sclerosis in Finland: A nationwide register-based cohort study.芬兰儿科创伤性脑损伤与早发性多发性硬化症:一项基于全国登记的队列研究。
Brain Behav. 2024 Apr;14(4):e3478. doi: 10.1002/brb3.3478.
7
Frequency of Registered Cases of Multiple Sclerosis.多发性硬化症登记病例的频率。
Maedica (Bucur). 2023 Jun;18(2):216-221. doi: 10.26574/maedica.2023.18.2.216.
8
Multimodal diagnostics in multiple sclerosis: predicting disability and conversion from relapsing-remitting to secondary progressive disease course - protocol for systematic review and meta-analysis.多发性硬化症的多模态诊断:预测残疾和从复发缓解型向继发性进展型病程的转化-系统评价和荟萃分析方案。
BMJ Open. 2023 Jul 14;13(7):e068608. doi: 10.1136/bmjopen-2022-068608.
9
Adult-Onset Neuroepidemiology in Finland: Lessons to Learn and Work to Do.芬兰的成人发病神经流行病学:可汲取的经验教训与待开展的工作
J Clin Med. 2023 Jun 11;12(12):3972. doi: 10.3390/jcm12123972.
10
Multiple sclerosis epidemiological trends in Italy highlight the environmental risk factors.意大利多发性硬化症的流行病学趋势强调了环境危险因素。
J Neurol. 2022 Apr;269(4):1817-1824. doi: 10.1007/s00415-021-10782-5. Epub 2021 Sep 27.